EUVIMEDEUVIMED entdecken
Crossref

Alpha-lipoic Acid Prevents Bone Loss in Type 2 Diabetes and Postmenopausal Osteoporosis Coexisting Conditions by Modulating the YAP/Glut4 Pathway

Lei Xu, Chunfang Zhang, Jiawu Bao, Guozhu Han, Changyuan Wang, Yuanqing Cai, Gang Xu, Huijun Sun, Mozhen Liu

Cell Biochemistry and Biophysics · 2024

DOI: 10.1007/s12013-024-01216-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2024. Verfasst von Lei Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Office of Ethics Committee, the First Affiliated Hospital, Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Thioctic Acid, Diabetes Mellitus, Type 2, Osteoporosis, Postmenopausal, Glucose Transporter Type 4. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to characterize the bone-protecting effects of Alpha-lipoic acid (ALA), a potent antioxidant, against the detrimental effects of the coexistence of type 2 diabetes mellitus (T2DM) and postmenopausal osteoporosis (POP) and identify the possible mechanisms with particular reference to its modulation of YAP/Glut4 pathway. The T2DM and POP coexisting model was induced in mice by high fat diet (HFD) + Streptozocin (STZ) + ovariectomy (OVX). The mice in the treatment groups were given ALA for 10 weeks. In the in vitro study, MC3T3-E1 cells were induced with 500 μM methylglyoxal for 24 h with or without pretreatment with ALA for 24 h. The oxidative and antioxidative biomarkers, bone microarchitecture, histo-morphology, and related protein expression of apoptosis, osteogenic differentiation and the YAP/Glut4 pathway were detected. The results showed ALA could improve glucose tolerance, inhibit oxidative stress and apoptosis and alleviate bone loss. Further study by siRNA technology revealed that the YAP/Glut4 pathway was implicated in the pathogenesis of bone loss due to the coexistence of T2DM and POP. Taken together, the present study has demonstrated for the first time that ALA exerts potent protective effects against bone loss in T2DM and POP coexisting conditions by modulating the YAP/Glut4 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thioctic AcidDiabetes Mellitus, Type 2Osteoporosis, PostmenopausalGlucose Transporter Type 4YAP-Signaling ProteinsOxidative StressAnimalsMiceFemaleSignal TransductionAdaptor Proteins, Signal TransducingMice, Inbred C57BLApoptosisCell LineDiet, High-FatHumansOvariectomyAntioxidantsCell DifferentiationTranscription FactorsDiabetes Mellitus, ExperimentalOsteogenesis

Stichwörter der Autor:innen

Alpha-lipoic acidAntioxidantPostmenopausal osteoporosisType 2 diabetes mellitusYAP/Glut4 pathway

Substanzen

Thioctic AcidGlucose Transporter Type 4YAP-Signaling ProteinsYap1 protein, mouseAdaptor Proteins, Signal TransducingAntioxidantsTranscription Factors

Autor:innen und Institutionen

  • Office of Ethics Committee, the First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Department of Pathology, the First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China.
  • Department of Orthopaedics, the First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China. sunhuijun@dmu.edu.cn.
  • Department of Orthopaedics, the First Affiliated Hospital, Dalian Medical University, Dalian, China. mozhenliu@dmu.edu.cn.

Zitieren

APA

Xu, L., Zhang, C., Bao, J., Han, G., Wang, C., Cai, Y., Xu, G., Sun, H., & Liu, M. (2024). Alpha-lipoic Acid Prevents Bone Loss in Type 2 Diabetes and Postmenopausal Osteoporosis Coexisting Conditions by Modulating the YAP/Glut4 Pathway. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-024-01216-w

Vancouver

Xu L, Zhang C, Bao J, Han G, Wang C, Cai Y, et al. Alpha-lipoic Acid Prevents Bone Loss in Type 2 Diabetes and Postmenopausal Osteoporosis Coexisting Conditions by Modulating the YAP/Glut4 Pathway. Cell Biochemistry and Biophysics. 2024. doi:10.1007/s12013-024-01216-w

BibTeX
@article{Xu2024,
  author = {Xu, Lei and Zhang, Chunfang and Bao, Jiawu and Han, Guozhu and Wang, Changyuan and Cai, Yuanqing and Xu, Gang and Sun, Huijun and Liu, Mozhen},
  title = {Alpha-lipoic Acid Prevents Bone Loss in Type 2 Diabetes and Postmenopausal Osteoporosis Coexisting Conditions by Modulating the YAP/Glut4 Pathway},
  journal = {Cell Biochemistry and Biophysics},
  year = {2024},
  doi = {10.1007/s12013-024-01216-w}
}
Kostenlos starten →